Clifutinib clinical trials
Includes 2 studies of Clifutinib Besylate.
How each study uses clifutinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the clifutinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 1 in phase 3
Studies that test clifutinib, phase 3 first.
- Nov 2027HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AMLPhase 3 · Sunshine Lake Pharma Co., Ltd.
- Apr 2027A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy ParticipantsPhase 1 · Sunshine Lake Pharma Co., Ltd.
Studies
Open first, then newest update. How each study uses clifutinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AMLRecruitingPhase 1/2Sunshine Lake Pharma Co., Ltd.NCT05133882Written as Clifutinib Besylate
- HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AMLRecruitingPhase 3Sunshine Lake Pharma Co., Ltd.NCT05586074Written as Clifutinib
- A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy ParticipantsNot yet recruitingPhase 1Sunshine Lake Pharma Co., Ltd.NCT07341672Written as Clifutinib
- Clinical Study on the Mass Balance of ClifutinibCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT07211165Written as [14C]Clifutinib
- A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)CompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT04827069Written as Clifutinib Besylate
Codes
What other systems call clifutinib · ClinicalTrials.gg INT014637
- Wikidata Q140528737clifutinibOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q140528737 | clifutinib | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.